Kaur, Hardeep

Indian contribution toward biomedical research and development in COVID‑19 : A systematic review - Vol.53(1), Jan-Feb - Mumbai Wolter Kluwer 2021 - 63-72p.

COVID‑19 pandemic led to an unprecedented collaborative effort among industry, academia,
regulatory bodies, and governments with huge financial investments. Scientists and researchers
from India also left no stone unturned to find therapeutic and preventive measures against
COVID‑19. Indian pharmaceutical companies are one of the leading manufacturers of vaccine
in the world, are utilizing its capacity to its maximum, and are one among the forerunners in
vaccine research against COVID‑19 across the globe. In this systematic review, the information
regarding contribution of Indian scientists toward COVID‑19 research has been gathered from
various news articles across Google platform apart from searching PubMed, WHO site, COVID‑19
vaccine tracker, CTRI, clinicaltrials.gov, and websites of pharmaceutical companies. The article
summarizes and highlights the various therapeutic and vaccine candidates, diagnostic kits,
treatment agents, and technology being developed and tested by Indian researcher community
against COVID‑19.


PHARMACOLOGY
Unique Visitors hit counter Total Page Views free counter
Implemented and Maintained by AIKTC-KRRC (Central Library).
For any Suggestions/Query Contact to library or Email: librarian@aiktc.ac.in | Ph:+91 22 27481247
Website/OPAC best viewed in Mozilla Browser in 1366X768 Resolution.

Powered by Koha